Breaking
•eToro acquires Argentina’s LB Finanzas to expand into Latin America - Citywire•Pope Leo to head home to Latin America for his longest and farthest trip yet - The Independent•Extension of Mohamud's presidential term unlawful, Somalia's Supreme Court rules - Africanews•A theatre festival in Morocco's capital celebrates six women directors - Africanews•Ukraine's Zelenskiy Appeals for Energy Infrastructure Aid at Madrid Summit - U.S. News & World Report•Russia Iran - Post Register•APTOPIX Britain Russell Brand - Post Register•Emirates Dubai Design Week - Post Register•France: Hundreds of thousands participate in national protest-strike day - upi•Paraguay President Santiago Peña resigns following bank collapse - KSAT•Rory McIlroy handed 2-shot penalty, admits video 'doesn't look very good' - ESPN•Harbaugh on Rams DB's 'deli meat' comment on Herbert: 'It's not what I see' - ESPN•Republicans hoping to succeed Trump in 2028 dissect midterm rout•K-Pop, Country, Latin: Sony’s Global Roster Drives Double-Digit Revenue Growth•Banned tobacco products worth ₹7 crore seized in Ernakulam; seven held•ZPTC, MPTC elections in Andhra Pradesh by and large peaceful•Two actors held on charge of assaulting and robbing doctor in Kochi•Ninth tranche of mineral block auctions offers 20 blocks•States asked to flag data quality concerns, make corrections in real time during Census 2027•PM assures Karnataka CM of full support in water conservation, management•eToro acquires Argentina’s LB Finanzas to expand into Latin America - Citywire•Pope Leo to head home to Latin America for his longest and farthest trip yet - The Independent•Extension of Mohamud's presidential term unlawful, Somalia's Supreme Court rules - Africanews•A theatre festival in Morocco's capital celebrates six women directors - Africanews•Ukraine's Zelenskiy Appeals for Energy Infrastructure Aid at Madrid Summit - U.S. News & World Report•Russia Iran - Post Register•APTOPIX Britain Russell Brand - Post Register•Emirates Dubai Design Week - Post Register•France: Hundreds of thousands participate in national protest-strike day - upi•Paraguay President Santiago Peña resigns following bank collapse - KSAT•Rory McIlroy handed 2-shot penalty, admits video 'doesn't look very good' - ESPN•Harbaugh on Rams DB's 'deli meat' comment on Herbert: 'It's not what I see' - ESPN•Republicans hoping to succeed Trump in 2028 dissect midterm rout•K-Pop, Country, Latin: Sony’s Global Roster Drives Double-Digit Revenue Growth•Banned tobacco products worth ₹7 crore seized in Ernakulam; seven held•ZPTC, MPTC elections in Andhra Pradesh by and large peaceful•Two actors held on charge of assaulting and robbing doctor in Kochi•Ninth tranche of mineral block auctions offers 20 blocks•States asked to flag data quality concerns, make corrections in real time during Census 2027•PM assures Karnataka CM of full support in water conservation, management
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more

Confidence88·multiple reportsImportance90NP-EVT-20261105-14D9870

India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing

Read the original at the primary source
STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more
Ed Silverman · 11/5/2026, 2:49:16 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —